Charles River Laboratories (NYSE:CRL)
CAPS Rating:
The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.
RSS Headlines
Fool UK
Recs
I haven't been watching these stocks long, but these look the most appetizing as of right now.